Cipla Ltd.

BSE: 500087 | NSE: CIPLA

Large Cap | Pharmaceuticals & Drugs

1438.75

-2.95 (-0.20%)

< Home < Back

Cipla informs about press release

Date: 26-03-2020

Cipla has informed that the company has enclosed press release dated 26th March 2020 regarding ‘Cipla receives final approval for generic version of AstraZeneca Pharmaceutical’s Nexium (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)’.

The above information is a part of company’s filings submitted to BSE.